Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...

The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.

Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

Is it really okay to get flu and COVID-19 vaccines together? What about adding in an RSV vaccine or another type of shot? Here’s what the experts have to say. Vaccines have changed modern ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...

According to Research by , Vaccine Market Growth is Driven by Increasing Government Support, Technological Innovations, and Growing Demand for Immunization, with Key Contributions from mRNA and ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly ...

Novavax’s decision has left managers of the Biologics Manufacturing Centre, which was built with nearly $130-million in ...

We recently compiled a list of the 7 Best Under The Radar Stocks to Buy According to Analysts. In this article, we are going ...